title: What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews.
authors.affiliation: Janssen, Neuss, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Gaudig
authors.affiliation: Janssen, High Wycombe, UK.
authors.forename: S
authors.initials: S
authors.lastname: Ireland
authors.affiliation: Janssen, High Wycombe, UK.
authors.forename: P
authors.initials: P
authors.lastname: Musingarimi
authors.affiliation: Adelphi Research UK, Bollington, UK.
authors.forename: C
authors.initials: C
authors.lastname: Jackson
authors.affiliation: Adelphi Research UK, Bollington, UK.
authors.forename: E
authors.initials: E
authors.lastname: Tweats
authors.affiliation: OptumInsight, Stockholm, Sweden.
authors.forename: J A
authors.initials: JA
authors.lastname: Eriksson
authors.affiliation: OptumInsight, Stockholm, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Landfeldt